Eternity Healthcare Announces Financing Completed in the Amount of $1.3 Million U.S. Dollars
(firmenpresse) - VANCOUVER, BC and PHOENIX, AZ -- (Marketwired) -- 08/29/13 -- (OTCQB: ETAH), or the "Company," a biopharmaceutical company with technologies in drug delivery, specialty pharmaceuticals and medical devices, announced today that it has completed a financing in the amount of $1,362,434 for issuance of 2,724,868 Common Shares to international investors. The Company sold restricted Common Shares at a price of $0.50 per share under Regulation S which are subject to rule 144. The Common Shares issued are restricted for resale until either a registration statement is filed with the Security and Exchange Commission or the time period for registration expires under rule 144 and restriction legends are removed.
The Company plans to use the proceeds of this financing to implement a strong product marketing program, for the sales and commercialization of its products to further business development.
"We continue to progress in our business development strategy we see tremendous growth potential in our product sales channels and have fulfilled the need to maintain sufficient funds to achieve such goals without making an un-necessary dilution to shareholders equity," said Dr. Salari, President & CEO of Eternity Healthcare.
. (OTCQB: ETAH)
Eternity Healthcare is a biopharmaceutical company with technologies in drug delivery, specialty pharmaceuticals and medical devices. We are currently focusing on the development of new subcutaneous formulation of otherwise intramuscular injectable drugs and needle-free injection systems. Our products are sold to healthcare professionals, for use in physicians' offices, pharmacies, and to consumers directly. Our products are all manufactured under strictly compliant with GMP, ISO 9001 and ISO 13485 procedures, with special emphasis on quality control at each and every stage of production. More information on Eternity Healthcare Inc. can be found on the website.
This release includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as ETAH or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Wall Street Media Group
Mr. Brian Andrew
1 (480) 228-9667
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.08.2013 - 06:26 Uhr
Sprache: Deutsch
News-ID 1259032
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
VANCOUVER, BC and PHOENIX, AZ
Phone:
Kategorie:
Venture Capital
Anmerkungen:
Diese Pressemitteilung wurde bisher 85 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Eternity Healthcare Announces Financing Completed in the Amount of $1.3 Million U.S. Dollars
"
steht unter der journalistisch-redaktionellen Verantwortung von
Eternity Healthcare (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
